Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2007-08-29 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
PROXY FORM
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use by shareholders at an extraordinary general meeting (EGM) of Uni-Bio Science Group Limited. It includes instructions for appointing a proxy to vote on resolutions related to share allotment mandates and share option schemes. The content is procedural and related to soliciting shareholder votes rather than reporting financial results or management commentary. It is not a report itself but a form used in the context of a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2007-08-29 English
REFRESHMENT OF THE EXISTING GENERAL MANDATE TO ALLOT AND ISSUE SHARES AND THE 10% GENERAL SCHEME LIMIT ON THE GRANT OF OPTIONS UNDER THE SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETIN
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from the Board of Uni-Bio Science Group Limited dated 29 August 2007. It discusses the refreshment of the existing general mandate to allot and issue shares and the 10% general scheme limit on the grant of options under the share option scheme. It includes a notice of an Extraordinary General Meeting (EGM) to approve these proposals. The content is focused on corporate governance matters related to share issuance mandates and share option schemes, and it includes a proxy form and meeting notice. There is no financial data or earnings information, nor is it a report of voting results or a regulatory announcement. The document is a detailed communication to shareholders about governance and capital structure proposals to be voted on at an EGM. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2007-08-29 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'NOTICE OF EXTRAORDINARY GENERAL MEETING' and contains detailed information about the agenda and resolutions to be considered at the meeting, including mandates to allot and issue shares, share option scheme refreshment, and procedural notes about proxies. It is a formal notice announcing the convening of an extraordinary general meeting (EGM) rather than the minutes, results, or materials of the meeting itself. The content is focused on informing shareholders about the meeting and the proposed resolutions to be voted on. There are no financial statements, audit opinions, or detailed management discussions present. The document length is 9364 characters, which is consistent with a detailed meeting notice. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings, especially extraordinary general meetings.
2007-08-29 English
ADJUSTMENTS RELATING TO SHARE OPTIONS AND WARRANTS
Capital/Financing Update Classification · 95% confidence The document is an announcement by the board of directors regarding adjustments to share options and warrants following a bonus issue approved at the annual general meeting. It references compliance with Listing Rules and includes detailed adjustments to exercise prices and number of shares. The document is an announcement of changes related to share options and warrants, not a full financial report or audit. It is not a report publication announcement since it contains substantive adjustment details. The content fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure and share option adjustments following a bonus issue.
2007-08-28 English
COMPLETION OF THE ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF ZETHANEL PROPERTIES LIMITED
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of an acquisition transaction, specifically the acquisition of the entire issued share capital of Zethanel Properties Limited by Uni-Bio Science Group Limited. It details the consideration paid, including cash and issuance of shares, and references prior announcements and circulars related to the acquisition. The document does not contain financial statements or detailed financial analysis but rather provides an update on a capital transaction. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share issuance related to acquisitions.
2007-08-22 English
UNUSUAL PRICE MOVEMENT
Regulatory Filings Classification · 95% confidence The document is a short announcement titled 'UNUSUAL PRICE MOVEMENT' made at the request of The Stock Exchange of Hong Kong Limited. It states that the directors are not aware of any reasons for the recent share price increase and confirms no discloseable negotiations or price-sensitive information under the Listing Rules. The document is brief (1386 characters) and does not contain financial data, management discussion, or detailed report content. It is a regulatory announcement addressing market price movement and compliance with listing rules, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2007-08-22 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.